INOTEK PHARMACEUTICALS CORP RCKT 5.75 08.01.21
NOTE 5.750% 8/0 · US DOMESTIC · CUSIP 45780VAB8
4
institutional holders
-5 vs Q4 2019
$13.5mprincipal reported held*
$13.4mreported value*
0 new
0 added
0 reduced
5 sold out
net sold ≈ $42.5m
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable.
Trends to Q1 2020
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q4 2019 | 9 |
| Q1 2020 | 4 |
Biggest buyers
| None |
Biggest sellers
| DeepCurrents Investment Group LLC | Sold out | -18.1m |
| CITADEL ADVISORS LLC | Sold out | -14.8m |
| Verition Fund Management LLC | Sold out | -7.3m |
| CREDIT SUISSE AG/ | Sold out | -2.5m |
| Tetragon Partners GP Ltd | Sold out | -1.0m |
Holders, Q1 2020
| Manager | Shares | Change |
|---|---|---|
| WOLVERINE ASSET MANAGEMENT LLC 0.14% of their portfolio | 7.5m $7.3m | Unchanged |
| DEUTSCHE BANK AG\ 0.00% of their portfolio | 4.0m $4.2m | Unchanged |
| Bruce & Co., Inc. 0.43% of their portfolio | 2.0m $1.9m | Unchanged |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | Unchanged |